ELVN logo

Enliven Therapeutics, Inc. (ELVN) EBITDA

annual EBITDA:

-$104.24M-$21.00M(-25.24%)
December 31, 2024

Summary

  • As of today (August 1, 2025), ELVN annual EBITDA is -$104.24 million, with the most recent change of -$21.00 million (-25.24%) on December 31, 2024.
  • During the last 3 years, ELVN annual EBITDA has fallen by -$79.59 million (-322.92%).
  • ELVN annual EBITDA is now -1024.09% below its all-time high of -$9.27 million, reached on December 1, 2020.

Performance

1-year change

-25.24%

3-year change

-322.92%

5-year change

-1024.09%

15-year change

-1024.09%

ELVN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

17.16%
ELVN annual EBITDA is higher than 17.16% of companies in Healthcare sector

Range

All-time high

-$9.27M

3-year low

-$104.24M
ELVN annual EBITDA is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
ELVN previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
ELVN next annual earnings announcement has not yet been scheduled

OtherELVNincome statement metrics

Annual revenue

-
ELVN annual revenue value is unknown

annual net income

-$89.02M
ELVN annual net profit is -$89.02 million

annual EBIT

-$104.55M
ELVN annual earnings before interest & taxes is -$104.55 million

Annual EPS

-$1.89
ELVN annual earnings per share is -$1.89

quarterly EBITDA:

-$31.62M-$4.80M(-17.91%)
March 31, 2025

Summary

  • As of today (August 1, 2025), ELVN quarterly EBITDA is -$31.62 million, with the most recent change of -$4.80 million (-17.91%) on March 31, 2025.
  • Over the past year, ELVN quarterly EBITDA has dropped by -$5.71 million (-22.04%).
  • ELVN quarterly EBITDA is now -278.13% below its all-time high of -$8.36 million, reached on December 1, 2021.

Performance

3-month change

-17.91%

1-year change

-22.04%

3-year change

-266%

5-year change

-278.13%

ELVN quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

15.64%
ELVN quarterly EBITDA is higher than 15.64% of companies in Healthcare sector

Range

All-time high

-$8.36M

3-year low

-$31.62M
ELVN quarterly EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
ELVN previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 13, 2025
ELVN next earnings announcement is scheduled for Aug 13, 2025

OtherELVNincome statement metrics

Quarterly revenue

-
ELVN quarterly revenue value is unknown

quarterly net income

-$28.54M
ELVN quarterly net profit is -$28.54 million

quarterly EBIT

-$31.69M
ELVN quarterly earnings before interest & taxes is -$31.69 million

Quarterly EPS

-$0.57
ELVN quarterly earnings per share is -$0.57

TTM EBITDA:

-$109.95M-$5.71M(-5.48%)
March 31, 2025

Summary

  • As of today (August 1, 2025), ELVN TTM EBITDA is -$109.95 million, with the most recent change of -$5.71 million (-5.48%) on March 31, 2025.
  • Over the past year, ELVN TTM EBITDA has dropped by -$17.16 million (-18.49%).
  • ELVN TTM EBITDA is now -1214.85% below its all-time high of -$8.36 million, reached on December 1, 2021.

Performance

3-month change

-5.48%

1-year change

-18.49%

3-year change

-546.71%

5-year change

-1214.85%

ELVN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

16.67%
ELVN TTM EBITDA is higher than 16.67% of companies in Healthcare sector

Range

All-time high

-$8.36M

3-year low

-$109.95M
ELVN TTM EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
ELVN previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 13, 2025
ELVN next earnings announcement is scheduled for Aug 13, 2025

OtherELVNincome statement metrics

TTM revenue

-
ELVN TTM revenue value is unknown

TTM net income

-$94.83M
ELVN TTM net profit is -$94.83 million

TTM EBIT

-$110.26M
ELVN TTM earnings before interest & taxes is -$110.26 million

TTM EPS

-$1.92
ELVN TTM earnings per share is -$1.92

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$104.24M
ELVN annual EBITDA is -$104.24 million

annual net income

-$89.02M
ELVN annual net profit is -$89.02 million

annual interest expense

-
ELVN annual interest expense value is unknown

annual income tax

$232.00K
ELVN annual income tax is $232.00 thousand

annual D&A

$317.00K
ELVN annual depreciation & amortization is $317.00 thousand

ELVN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.2%-22.0%-18.5%
3 y3 years-322.9%-266.0%-546.7%
5 y5 years-1024.1%-278.1%-1214.8%

ELVN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-322.9%at low-252.7%at low-323.4%at low
5 y5-year-1024.1%at low-278.1%at low-1214.8%at low
alltimeall time-1024.1%at low-278.1%at low-1214.8%at low

ELVN EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$31.62M(+17.9%)
-$109.95M(+5.5%)
Dec 2024
-$104.24M(+25.2%)
-$26.82M(-0.6%)
-$104.24M(+4.2%)
Sep 2024
-
-$26.99M(+10.0%)
-$100.07M(+2.9%)
Jun 2024
-
-$24.52M(-5.3%)
-$97.25M(+4.8%)
Mar 2024
-
-$25.91M(+14.4%)
-$92.79M(+11.5%)
Dec 2023
-$83.23M
-$22.65M(-6.3%)
-$83.23M(+17.8%)
Sep 2023
-
-$24.17M(+20.5%)
-$70.68M(+23.2%)
Jun 2023
-
-$20.06M(+22.7%)
-$57.38M(+24.0%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$16.35M(+61.9%)
-$46.29M(+20.0%)
Dec 2022
-$38.58M(+56.5%)
-$10.10M(-7.1%)
-$38.58M(+4.7%)
Sep 2022
-
-$10.87M(+21.3%)
-$36.84M(+41.9%)
Jun 2022
-
-$8.96M(+3.8%)
-$25.96M(+52.7%)
Mar 2022
-
-$8.64M(+3.3%)
-$17.00M(+103.3%)
Dec 2021
-$24.65M(+165.8%)
-
-
Dec 2021
-
-$8.36M
-$8.36M
Dec 2020
-$9.27M
-
-

FAQ

  • What is Enliven Therapeutics, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual EBITDA year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly EBITDA year-on-year change?
  • What is Enliven Therapeutics, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. TTM EBITDA year-on-year change?

What is Enliven Therapeutics, Inc. annual EBITDA?

The current annual EBITDA of ELVN is -$104.24M

What is the all time high annual EBITDA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual EBITDA is -$9.27M

What is Enliven Therapeutics, Inc. annual EBITDA year-on-year change?

Over the past year, ELVN annual EBITDA has changed by -$21.00M (-25.24%)

What is Enliven Therapeutics, Inc. quarterly EBITDA?

The current quarterly EBITDA of ELVN is -$31.62M

What is the all time high quarterly EBITDA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly EBITDA is -$8.36M

What is Enliven Therapeutics, Inc. quarterly EBITDA year-on-year change?

Over the past year, ELVN quarterly EBITDA has changed by -$5.71M (-22.04%)

What is Enliven Therapeutics, Inc. TTM EBITDA?

The current TTM EBITDA of ELVN is -$109.95M

What is the all time high TTM EBITDA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high TTM EBITDA is -$8.36M

What is Enliven Therapeutics, Inc. TTM EBITDA year-on-year change?

Over the past year, ELVN TTM EBITDA has changed by -$17.16M (-18.49%)
On this page